Searched for
HESTER BIOSCIENCES SHARES
Ahead of Market: 10 things that will decide stock market action on FridayDomestic equity benchmarks ended marginally lower for a second consecutive session as weakness in financial, IT and energy shares offset ga...- Hester Biosciences surges up to 13% in a weak market. What's fuelling the gain?Meanwhile to manufacture additional quantities of the vaccine and to ensure the continuance of the manufacturing and the supply of all othe...
- Hester Biosciences to roll out Covaxin drug substance by April 2022Ahmedabad-based Hester Biosciences is a part of Gujarat Covid Vaccine Consortium (GCVC), which in May this year signed an agreement with Bh...
- Hester Biosciences Q1 results: Net profit jumps two-fold to Rs 11 crRevenue from operations stood at Rs 60.18 crore in the quarter under review. It was Rs 39.85 crore in the same period a year ago, it added.
- Hester Biosciences Q4 results: Profit jumps over two folds to Rs 10 crConsolidated revenue from operations stood at Rs 64.17 crore in the quarter under review. It was Rs 43.62 crore in the same period a year a...
- Hester Biosciences jumps as company inks Covaxin pactThe scrip jumped 14 per cent to Rs 3,099 in early deals, but gave up some of those gains to trade at Rs 2,914.75 at 11:00 am.
- Pact signed between Bharat Biotech, Gujarat Covid Vaccine Consortium: Hester BiosciencesGCVC comprises Gujarat Biotechnology Research Centre (GBRC), Hester Biosciences and Omnibrx Biotechnologies Pvt Ltd, Hester Biosciences sai...
- Hester Biosciences jumps 19% on Covaxin buzzThe pharma maker said it has tied up with the Gujarat government to explore production of COVID-19 vaccine through technology transfer from...
- Hester in talks with Bharat Biotech for production of COVID-19 vaccine via technology transfer"A triparty consortium has been formed with the Government of Gujarat as the lead partner, to explore the prospects of manufacturing the Co...
- Hester Biosciences Q3 results: Net profit up 8% at Rs 13 croreConsolidated net sales of the company stood at Rs 56.89 crore for the quarter under consideration. It was Rs 50.69 crore for the same perio...
- This smallcap firm to work on Covid-19 vaccine; shares rally 20%Indian Institute of Technology Guwahati and Hester Biosciences expect the vaccine to be ready by the end of this year.
- Hester Biosciences December quarter profit drops 4% at Rs 12 croreShares of Hester Biosciences were trading at Rs 1,610, down 1.67 per cent on the BSE.
- Hester Biosciences approves raising up to Rs 150 cr via QIP, preferential allotmentThe board also approved reappointment of Rajiv Gandhi, CEO and MD of the company.
- Hester Biosciences Q3 net profit rises 82% to Rs 11.85 croreIts standalone net sales stood at Rs 41.55 crore for the quarter.
- Hester Biosciences Q4 net up 29% at Rs 7 croreStandalone net sales of the company also rose to Rs 34.93 crore for the quarter under consideration as against Rs 28.18 crore for the same ...
- Hester Biosciences Q3 net zooms 22% to Rs 5.8 croreStandalone net sales of the company also rose to Rs 28.52 crore for the quarter under consideration as against Rs 24.17 crore for the same ...
- Hester Biosciences Q2 net profit up 39% at Rs 6 crStandalone net sales of the company also rose to Rs 29.63 crore for the quarter under review as against Rs 24 crore for the same period las...
- Hester Biosciences Q4 net profit rises 57% to Rs 5.5 croreThe company had posted a net profit of Rs 3.5 crore in the same quarter last fiscal, Hester Biosciences said in a BSE filing.
- Hester Biosciences Q3 net up 41% at Rs 4.75 croreThe company had posted a net profit of Rs 3.37 crore in the same quarter of the previous fiscal, Hester Biosciences said in a regulatory fi...
- Hester Biosciences board approves scheme of amalgamation and arrangementFor merger of Diavetra, GAFL and Hester Mauritius into Hester India, no shares of Hester India will be issued on amalgamation, Hester Biosc...
Load More
